Instituto Rosenbusch's revenue for the
three
months ended in Mar. 2024 was ARS1,960 Mil.
Its revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ARS5,175 Mil.
Instituto Rosenbusch's Revenue per Share for the
three
months ended in Mar. 2024 was ARS46.01.
Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ARS121.51.
Warning Sign:
Instituto Rosenbusch SA revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Instituto Rosenbusch was 28.00% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 75.10% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 67.80% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 51.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 13 years, Instituto Rosenbusch's highest 3-Year average Revenue per Share Growth Rate was 96.80% per year. The lowest was -80.70% per year. And the median was 15.90% per year.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Instituto Rosenbusch's Revenue
For the Drug Manufacturers - Specialty & Generic subindustry, Instituto Rosenbusch's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Instituto Rosenbusch's Revenue Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Instituto Rosenbusch's Revenue distribution charts can be found below:
* The bar in red indicates where Instituto Rosenbusch's Revenue falls into.
Instituto Rosenbusch Revenue Calculation
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ARS5,175 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Instituto Rosenbusch (BUE:ROSE) Revenue Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Instituto Rosenbusch Revenue Related Terms
Thank you for viewing the detailed overview of Instituto Rosenbusch's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Instituto Rosenbusch (BUE:ROSE) Business Description
Instituto Rosenbusch SA is a pharmaceutical company based in Argentina. The company is engaged in the processing and industrialization of biological, chemical, pharmaceutical products of any kind, nature or destination, preferably for veterinary use or intended to combat pests and diseases of the agricultural exploitation. The company has line of products such as Biologicals and pharmaceuticals. Biologicals offer Campy 3, Cultivac 6M and Bovine Antibrucelosis. Pharmaceuticals offer Diclosan A Intrammamary, Diclosan S Intrammamary and Mastilina V-S.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BUE:ROSE has been successfully added to your 